199 related articles for article (PubMed ID: 33002404)
1. DNA N6-methyladenine increased in human esophageal squamous cell carcinoma.
Chen L; Zhang M; Guo M
Discov Med; 2020; 29(157):85-90. PubMed ID: 33002404
[TBL] [Abstract][Full Text] [Related]
2. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma.
Liu L; Zhang S; Liu X; Liu J
Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
[TBL] [Abstract][Full Text] [Related]
6. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
[TBL] [Abstract][Full Text] [Related]
7. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
Su JF; Zhao F; Gao ZW; Hou YJ; Li YY; Duan LJ; Lun SM; Yang HJ; Li JK; Dai NT; Shen FF; Zhou FY
Pathol Res Pract; 2020 Apr; 216(4):152848. PubMed ID: 32051106
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers.
Talukdar FR; Soares Lima SC; Khoueiry R; Laskar RS; Cuenin C; Sorroche BP; Boisson AC; Abedi-Ardekani B; Carreira C; Menya D; Dzamalala CP; Assefa M; Aseffa A; Miranda-Gonçalves V; Jerónimo C; Henrique RM; Shakeri R; Malekzadeh R; Gasmelseed N; Ellaithi M; Gangane N; Middleton DRS; Le Calvez-Kelm F; Ghantous A; Roux ML; Schüz J; McCormack V; Parker MI; Pinto LFR; Herceg Z
Cancer Res; 2021 May; 81(10):2612-2624. PubMed ID: 33741694
[TBL] [Abstract][Full Text] [Related]
10. Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Nohara K; Yamada K; Yamada L; Hagiwara T; Igari T; Yokoi C; Soma D; Yamashita S; Dohi T; Kawamura YI
Gen Thorac Cardiovasc Surg; 2018 Jun; 66(6):351-357. PubMed ID: 29582368
[TBL] [Abstract][Full Text] [Related]
11. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
12. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
14. Epigenetically Upregulated MicroRNA-602 Is Involved in a Negative Feedback Loop with FOXK2 in Esophageal Squamous Cell Carcinoma.
Liu M; Yu J; Wang D; Niu Y; Chen S; Gao P; Yang Z; Wang H; Zhang J; Zhang C; Zhao Y; Hu W; Sun G
Mol Ther; 2019 Oct; 27(10):1796-1809. PubMed ID: 31401147
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
[TBL] [Abstract][Full Text] [Related]
17. [Progress in genomic DNA methylation of esophageal squamous cell carcinoma].
Guo J; Hao JJ; Wang MR
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1176-1182. PubMed ID: 31683410
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
20. Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma.
Teng H; Xue M; Liang J; Wang X; Wang L; Wei W; Li C; Zhang Z; Li Q; Ran X; Shi X; Cai W; Wang W; Gao H; Sun Z
Theranostics; 2020; 10(7):3035-3048. PubMed ID: 32194853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
